Last10K.com

Rexahn Pharmaceuticals, Inc. (RNN) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Rexahn Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1228627 Ticker: RNN
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2011
Mar. 15, 2012
Jun. 30, 2011
Document and Entity Information      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2011    
Entity Registrant Name REXAHN PHARMACEUTICALS, INC.    
Entity Central Index Key 0001228627    
Current Fiscal Year End Date --12-31    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   95,345,656  
Document Fiscal Year Focus 2011    
Document Fiscal Period Focus FY    
Entity Public Float     $ 93,016,125
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    

View differences made from one year to another to evaluate Rexahn Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Rexahn Pharmaceuticals, Inc..

Continue

Assess how Rexahn Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Rexahn Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: RNN
CIK: 1228627
Form Type: 10-K Annual Report
Accession Number: 0001140361-12-016054
Submitted to the SEC: Thu Mar 15 2012 6:43:17 PM EST
Accepted by the SEC: Fri Mar 16 2012
Period: Saturday, December 31, 2011
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/rnn/0001140361-12-016054.htm